Cargando…
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock
BACKGROUND: The randomized DOREMI (Dobutamine Compared to Milrinone) clinical trial evaluated the efficacy and safety of milrinone and dobutamine in patients with cardiogenic shock. Whether the results remain consistent when stratified by acute myocardial infarction remains unknown. In this substudy...
Autores principales: | Jung, Richard G., Di Santo, Pietro, Mathew, Rebecca, Abdel‐Razek, Omar, Parlow, Simon, Simard, Trevor, Marbach, Jeffrey A., Gillmore, Taylor, Mao, Brennan, Bernick, Jordan, Theriault‐Lauzier, Pascal, Fu, Angel, Lau, Lawrence, Motazedian, Pouya, Russo, Juan J., Labinaz, Marino, Hibbert, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751815/ https://www.ncbi.nlm.nih.gov/pubmed/34713704 http://dx.doi.org/10.1161/JAHA.121.021570 |
Ejemplares similares
-
Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
por: Abdel-Razek, Omar, et al.
Publicado: (2023) -
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial
por: Marbach, Jeffrey A., et al.
Publicado: (2022) -
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
por: Di Santo, Pietro, et al.
Publicado: (2021) -
Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic
por: Simard, Trevor, et al.
Publicado: (2021) -
Female Authorship in Preclinical Cardiovascular Research: Temporal Trends and Influence on Experimental Design
por: Labinaz, Alisha, et al.
Publicado: (2019)